1. Home
  2. GDC vs NXL Comparison

GDC vs NXL Comparison

Compare GDC & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GD Culture Group Limited

GDC

GD Culture Group Limited

HOLD

Current Price

$1.45

Market Cap

6.5M

Sector

Industrials

ML Signal

HOLD

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

HOLD

Current Price

$4.92

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDC
NXL
Founded
2015
2010
Country
United States
United States
Employees
5
N/A
Industry
Steel/Iron Ore
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
GDC
NXL
Price
$1.45
$4.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.2M
76.3K
Earning Date
04-10-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.76
EPS
★ N/A
N/A
Revenue
N/A
★ $301,647.00
Revenue This Year
N/A
$15.52
Revenue Next Year
N/A
$100.00
P/E Ratio
$7.47
★ N/A
Revenue Growth
N/A
★ 78.78
52 Week Low
$0.01
$0.22
52 Week High
$8.18
$7.69

Technical Indicators

Market Signals
Indicator
GDC
NXL
Relative Strength Index (RSI) 50.78 63.18
Support Level $1.32 $4.51
Resistance Level $2.07 $7.69
Average True Range (ATR) 0.18 0.44
MACD 0.02 -0.16
Stochastic Oscillator 28.55 64.43

Price Performance

Historical Comparison
GDC
NXL

About GDC GD Culture Group Limited

GD Culture Group Ltd operates and manages its business as a single segment and has one operating and reportable segment, the Virtual Content Production. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: